Arbutus Biopharma (ABUS) received a Notice of Allowance for its US patent application 16/312,162 titled "COMPOSITIONS AND METHODS FOR DELIVERING MESSENGER RNA" - Patent Grants
Get Alerts ABUS Hot Sheet
Join SI Premium – FREE
Arbutus Biopharma (NASDAQ: ABUS) received a Notice of Allowance for its US patent application 16/312,162 titled "COMPOSITIONS AND METHODS FOR DELIVERING MESSENGER RNA" - Patent Grants
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Starbucks (SBUX) announces executives for new global leadership positions
- Cognizant (CTSH) to apply generative AI for drug discovery with Nvidia (NVDA)
- Chart Industries (GTLS) Awarded Order for Hydrogen Liquefier, Liquid Hydrogen Transports and ISO Containers from Element Resources
Create E-mail Alert Related Categories
Corporate NewsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!